Corbus Pharmaceuticals Hldgs Inc (CRBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -313 | -253 | -44 | -880 |
| Accounts payable and accrued liabilities | 40 | 18 | -1 | N/A |
| Other Working Capital | 11 | -8 | -6 | 30 |
| Other Operating Activity | 18 | 24 | 7 | 90 |
| Operating Cash Flow | $-244 | $-218 | $-44 | $-760 |
| Cash Flows From Investing Activities | ||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $0 |
| Cash Flows From Financing Activities | ||||
| Debt Issued | 7 | 4 | N/A | N/A |
| Other Financing Activity | 25 | 25 | 25 | 1,040 |
| Financing Cash Flow | $32 | $29 | $25 | $1,040 |
| Beginning Cash Position | 543 | 543 | 543 | 260 |
| End Cash Position | 331 | 353 | 523 | 540 |
| Net Cash Flow | $-211 | $-190 | $-19 | $270 |
| Free Cash Flow | ||||
| Operating Cash Flow | -244 | -218 | -44 | -760 |
| Free Cash Flow | -244 | -218 | -44 | -760 |